Search - tctmd.com

Displaying 541 - 560 of 6853

Sort: Relevancy | Date

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

News Conference News TCT 2024

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

Caitlin E. Cox

November 04, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2024

Shelley Wood

November 01, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

Todd Neale

October 31, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

TCT 867: Vcal+CT: Detect, evaluate and prevent complications by accurately assessing vascular and valvular calcium

Presenter: Victor Alfonso Jimv©nez Dv?az

October 30, 2024

Presentation TCT 2024

TCT 868: Potential Pre-TAVR CT Based Computational Modeling Derived Geometric Predictors of Post-TAVR Leaflet Thrombosis in Self-Expandable Valves

Presenter: Aniket Venkatesh

October 30, 2024

Presentation TCT 2024

TCT 869: Insight From Pre and Post Redo-TAV Computed Tomography Assessment: Implication for Sizing, Positioning and Coronary Risk

Presenter: NULL

October 30, 2024

Presentation TCT 2024

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 866: Regional Left Intraventricular Systolic Pressure Gradients (IVPG) in the Nonobstructive Ventricle and Potential Impact on Invasive and Echo Aortic Valve Gradients

Presenter: Safwan Kassas

October 30, 2024

Presentation TCT 2024

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

TCT 1592: Management of Post-TAVR Severe PVL: A TAV-in-TAV Case

Presenter: Chloe Kharsa

October 30, 2024

Presentation TCT 2024

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Presenter: Julien Ternacle

October 30, 2024

Presentation TCT 2024

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Presenter: Philippe Pibarot

October 30, 2024

Advertisement

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

TCTMD’s Top 10 Most Popular Stories for October 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

TCT 867: Vcal+CT: Detect, evaluate and prevent complications by accurately assessing vascular and valvular calcium

TCT 868: Potential Pre-TAVR CT Based Computational Modeling Derived Geometric Predictors of Post-TAVR Leaflet Thrombosis in Self-Expandable Valves

TCT 869: Insight From Pre and Post Redo-TAV Computed Tomography Assessment: Implication for Sizing, Positioning and Coronary Risk

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

TCT 866: Regional Left Intraventricular Systolic Pressure Gradients (IVPG) in the Nonobstructive Ventricle and Potential Impact on Invasive and Echo Aortic Valve Gradients

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

TCT 1592: Management of Post-TAVR Severe PVL: A TAV-in-TAV Case

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content